Architect's drawing of new hospital
Cambridge Cancer
Cambridge Cancer (full name “the Cambridge Cancer Research Hospital”) is a partnership between Cambridge University Hospitals NHS Foundation Trust, the University of Cambridge and the Cancer Research UK Cambridge Centre.
In October 2020 Prime Minister Boris Johnson confirmed that the government would provide funding for Cambridge Cancer to be built adjacent to Addenbrooke’s Hospital on the Cambridge Biomedical Campus.
Additional fundraising and philanthropy will be needed, but the news of government funding accelerated an already ambitious plan that will lead ultimately to the building of the new hospital by 2025.
Dissolving the boundaries between care, technology and clinical knowledge.
Delivering for the UK
Delivering the UK Industrial Strategy
The UK Industrial Strategy aims to boost productivity and earning power across the country by focussing on the five foundations of productivity:
Ideas: the world’s most innovative economy
People: good jobs and greater earning power for all
Infrastructure: a major upgrade to the UK’s infrastructure
Business Environment: the best place to start and grow a business
Places: prosperous communities across the UK.
Delivering the NHS Long Term Plan for cancer
The plan aims to “save thousands more lives each year by dramatically improving how we diagnose and treat cancer – our ambition is that by 2028, an extra 55,000 people each year will survive for five years or more following their cancer diagnosis.”
Be fit for the future
1 Addenbrooke's and the Rosie Hospitals
2 University of Cambridge School of Clinical Medicine
3 Royal Papworth Hospital
4 World headquarters of Astra Zeneca
5 MRC Laboratory of Molecular Biology
6 Cancer Research UK Cambridge Institute
7 Jeffrey Cheah Biomedical Centre
8 Cambridge Cancer Trials Centre (CCTC)
and the Institute of Metabolic Science